Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Amgen · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
gastric-cancer
gastric cancer, gastroesophageal junction adenocarcinoma, bemarituzumab, fgfr2b overexpression, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 806247
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.